The North American market for Iliac Stents is expected to witness significant growth due to the increasing prevalence of peripheral artery disease (PAD) and the growing geriatric population in the region. The United States and Canada are the key countries contributing to the growth of the market in North America. Furthermore, the presence of well-established healthcare infrastructure and the high adoption of advanced medical technologies are also driving the market growth in this region.
Asia Pacific:
In Asia Pacific, countries such as China, Japan, and South Korea are expected to witness substantial growth in the Iliac Stents market. This growth can be attributed to the rising awareness about peripheral artery disease and the increasing healthcare expenditure in these countries. Additionally, the rapidly expanding geriatric population and the growing demand for minimally invasive procedures are further boosting the market growth in the region.
Europe:
The Iliac Stents market in Europe is also poised for significant growth, with the United Kingdom, Germany, and France emerging as key markets in the region. The increasing prevalence of lifestyle-related diseases and the rising demand for advanced medical devices are driving the market growth in these countries. Moreover, the presence of well-established healthcare facilities and the growing investments in healthcare infrastructure are contributing to the growth of the Iliac Stents market in Europe.
Overall, the Iliac Stents market is expected to witness substantial growth across North America, Asia Pacific, and Europe, driven by factors such as the increasing prevalence of peripheral artery disease, the growing geriatric population, and the rising adoption of advanced medical technologies in these regions.